Liquidia Technolgies Inc v. United Therapeutics Corp

Ivor Elrifi

George E. Quillin

Richard Torczon

Stephen B. Maebius

Sanya Sukduang

Shaun R. Snader

Daniel R. Shelton

Prosecution History analysis

Examiner Search analysis

Invalidity Framework analysis

Treprostinil (Remodulin®) product-by-process patent challenged for obviousness. Phares & Moriarty art cited against all 9 claims on synthesis methods.

United Therapeutics Corp

Liquidia Technologies Inc

Last Docket Entry Date

Total Docket Entries

IPR2020-00770 | Liquidia Technolgies Inc v. United Therapeutics Corp | Ex Parte

Patent Trial and Appeal Board

Judge	Cases	Inst. Rate	FWD Inv. Rate
Andrew Hirshfeld	100+	56%	81%
Erica A Franklin	400+	56%	70%
Jacqueline W Bonilla	400+	53%	71%
John E Schneider	40+	54%	74%
John E Schneider	40+	54%	74%
Scott R Boalick	200+	46%	80%
Zhenyu Yang	500+	55%	76%

Name	Ratings
Cooley LLP	L5 B
Ivor Elrifi	L2 C

Name	Ratings
Wilson Sonsini Goodrich & Rosati	L5 A
Richard Torczon	L5 A
Cooley LLP	L5 B
Sanya Sukduang	L5 E
Foley & Lardner LLP	L5 E
George E. Quillin	L5 A
Stephen B. Maebius	L3 B
Daniel R. Shelton	-- -- --
United Therapeutics Corp	-- -- --
Shaun R. Snader	-- -- --